CRYGC

Across TCGA pan-cancer cohorts, CRYGC RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of CRYGC’s most consistent transcriptional readouts.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where CRYGC RNA is more highly expressed in tumor relative to normal tissue. In most cancer types CRYGC is over-expressed in tumor.

HNSC and LUAD are the cancer types where CRYGC tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in CRYGC RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
HNSC	Male	II,III,IV	+0.131	<.001	10	view →
LUAD	All	All	+0.079	.021	4	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

CRYGC–HNSC

Open the HNSC breakdown →